Summary Microbio Co Ltd (Microbio) is a drug development company that discovers, develops, manufactures and commercializes drugs in the areas of cancer, autoimmune and other metabolic diseases. The company provides botanical drugs, monoclonal antibodies, new chemical entities, and glyco-molecules.
Its products include leeherb, oneness herb, cotton field, and microsoy. Microbio undertakes clinical trails for several drugs. The company’s products find application in the treatment of diseases such as fatigue and appetite loss, anemia, colorectal cancer, liver cancer, rheumatoid arthritis and hepatitis C, among others. Microbio is headquartered in Taipei, Taiwan.
Microbio Co Ltd (4128) - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.
GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.
Scope - Financial Deals - Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships. - Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period. - Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc. - Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America. - Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector. - Major Deals - Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios. - Business Description - A brief description of the company’s operations. - Key Employees - A list of the key executives of the company. - Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company. - Key Competitors - A list of the key competitors of the company. - Key Recent Developments - A brief on recent news about the company.
Reasons to Buy Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements - The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.
Understand the company’s business segments’ expansion / divestiture strategy - The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.
Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company - Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.
Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers. - The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company - Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research - Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note*: Some sections may be missing if data is unavailable for the company.
Our reports have been used by over 10K customers, including:
The Anticoagulants Market is expected to register a CAGR of 9.41% during the forecast period. Anticoagulants are used to treat and prevent blood clots which can block blood vessels (an artery or a vein) that can lead to serious complications as the clot disrupts the flow of blood to important organs and can result in heart attack and stroke. A...
227 pages •
By Asia Market Information & Development Company
• Jun 2020
China’s demand for Tuberculosis Treatment Drugs has grown at a fast pace in the past decade. In the next decade, both production and demand will continue to grow. The Chinese economy maintains a high speed growth which has been stimulated by the consecutive increases of industrial output, imports & exports,...
Diphtheria - Pipeline Review, H1 2020 Summary This latest Pharmaceutical and Healthcare disease pipeline guide Diphtheria – Pipeline Review, H1 2020, provides an overview of the Diphtheria (Infectious Disease) pipeline landscape. Diphtheria is a bacterial infection that affects the membranes...
Hemophilia A (Factor VIII Deficiency) Global Clinical Trials Review, H1, 2020 Summary This clinical trial report, “Hemophilia A (Factor VIII Deficiency) Global Clinical Trials Review, H1, 2020" provides an overview of Hemophilia A (Factor VIII Deficiency) Clinical trials scenario.This report provides...
In-depth Analysis and Data-driven Insights on the Impact of COVID-19 Included in this Global Syringe and Needle Market Report The syringe and needle market is expected to grow at a CAGR of over 10% during the period 2019–2025. The global syringe and needle market constitutes an essential segment of the global medical devices...
The growing prevalence of several types of cancers in cats and dogs, as well as an increase in R&D initiatives regarding cancer management in animals, is contributing to the growth of the market. According to the Veterinary Cancer Society, cancer was the leading cause of death in 47% of dogs, especially those that are over the age of 10, and...